Implicit and explicit dosimetry in photodynamic therapy: a New paradigm
暂无分享,去创建一个
[1] B. Wilson,et al. IN VIVO and POST MORTEM MEASUREMENTS OF THE ATTENUATION SPECTRA OF LIGHT IN MAMMALIAN TISSUES , 1985, Photochemistry and photobiology.
[2] J Moan,et al. Effect of bleaching of porphyrin sensitizers during photodynamic therapy. , 1986, Cancer letters.
[3] B. Henderson,et al. DRUG and LIGHT DOSE DEPENDENCE OF PHOTODYNAMIC THERAPY: A STUDY OF TUMOR and NORMAL TISSUE RESPONSE , 1987, Photochemistry and photobiology.
[4] J Moan,et al. Photoproducts formed from photofrin II in cells. , 1988, Journal of photochemistry and photobiology. B, Biology.
[5] J. Moore,et al. In vivo magnetic resonance imaging of the effects of photodynamic therapy. , 1989, British Journal of Cancer.
[6] W. Potter,et al. PDT Dosimetry And Response , 1989 .
[7] J. Moan,et al. On the diffusion length of singlet oxygen in cells and tissues , 1990 .
[8] M S Patterson,et al. In vivo TESTS OF THE CONCEPT OF PHOTODYNAMIC THRESHOLD DOSE IN NORMAL RAT LIVER PHOTOSENSITIZED BY ALUMINUM CHLOROSULPHONATED PHTHALOCYANINE , 1990, Photochemistry and photobiology.
[9] M S Patterson,et al. Experimental tests of the feasibility of singlet oxygen luminescence monitoring in vivo during photodynamic therapy. , 1990, Journal of photochemistry and photobiology. B, Biology.
[10] A. Welch,et al. A review of the optical properties of biological tissues , 1990 .
[11] T. Foster,et al. Oxygen consumption and diffusion effects in photodynamic therapy. , 1991, Radiation research.
[12] P Vaupel,et al. Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. , 1991, Cancer research.
[13] OPTICAL AND PHOTOBIOLOGICAL DOSIMETRY FOR PHOTODYNAMIC THERAPY OF SOLID TUMORS , 1992 .
[14] T. Foster,et al. Dosimetry in photodynamic therapy: oxygen and the critical importance of capillary density. , 1992, Radiation research.
[15] T L Phillips,et al. Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland. , 1993, Radiation research.
[16] Studies on pharmacokinetics of sulfonated aluminum phthalocyanine in a transplantable mouse tumor by in vivo fluorescence. , 1993, Journal of photochemistry and photobiology. B, Biology.
[17] Steven L. Jacques,et al. How photobleaching affects dosimetry and fluorescence monitoring of PDT in turbid media , 1993, Photonics West - Lasers and Applications in Science and Engineering.
[18] M G Nichols,et al. Fluence rate effects in photodynamic therapy of multicell tumor spheroids. , 1993, Cancer research.
[19] H. Sterenborg,et al. Quantification of the hematoporphyrin derivative by fluorescence measurementusing dual-wavelength excitation anddual-wavelength detection. , 1993, Applied optics.
[20] T. Dougherty. Photodynamic therapy. , 1993, Photochemistry and photobiology.
[21] H. Oppelaar,et al. Changes in perfusion of mouse tumours after photodynamic therapy , 1994, International journal of cancer.
[22] J. Devoisselle,et al. In vivo pH MEASUREMENT AND IMAGING OF TUMOR TISSUE USING A pH‐SENSITIVE FLUORESCENT PROBE (5,6–CARBOXYFLUORESCEIN): INSTRUMENTAL AND EXPERIMENTAL STUDIES , 1994, Photochemistry and photobiology.
[23] W. Mcgimpsey,et al. AN EFFICIENT OXYGEN INDEPENDENT TWO‐PHOTON PHOTOSENSITIZATION MECHANISM , 1994, Photochemistry and photobiology.
[24] Brian C. Wilson,et al. Theoretical study of the influence of sensitizer photobleaching on depth of necrosis in photodynamic therapy , 1994, Photonics West - Lasers and Applications in Science and Engineering.
[25] W. Star,et al. In vivo fluorescence kinetics and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: increased damage after multiple irradiations. , 1994, British Journal of Cancer.
[26] Kevin M. Smith,et al. EVALUATION OF NEW BENZOPORPHYRIN DERIVATIVES WITH ENHANCED PDT EFFICACY* , 1995, Photochemistry and photobiology.
[27] Hubert van den Bergh,et al. Clinical measurements of tissue optical properties in the esophagus and in the oral cavity , 1995, Other Conferences.
[28] W. Star. In vivo action spectra, absorption and fluorescence excitation spectra of photosensitizers for photodynamic therapy. , 1995, Journal of photochemistry and photobiology. B, Biology.
[29] Katsuo Aizawa,et al. Effectiveness of photodynamic therapy with a diode laser using mono-L-aspartyl chlorin e6 for implanted fibrosarcoma in mice , 1995, Other Conferences.
[30] T. Hasan,et al. The effects of aggregation, protein binding and cellular incorporation on the photophysical properties of benzoporphyrin derivative monoacid ring A (BPDMA). , 1995, Journal of photochemistry and photobiology. B, Biology.
[31] Hubert van den Bergh,et al. Evaluation with mTHPC of early squamous cell carcinomas of the cheek pouch mucosa of Golden Syrian hamsters as a model for clinical PDT of early cancers in the upper aerodigestive tract, the esophag , 1995, Other Conferences.
[32] Daniel Braichotte,et al. Clinical pharmacokinetic studies of tetra(meta‐hydroxyphenyl)chlorin in squamous cell carcinoma by fluorescence spectroscopy at 2 wavelengths , 1995, International journal of cancer.
[33] Stefan Andersson-Engels,et al. Multi-colour fluorescence imaging in connection with photodynamic therapy of delta-amino levulinic acid (ALA) sensitised skin malignancies , 1995 .
[34] Steven L. Jacques,et al. Kinetics of ALA-induced protoporphyrin IX accumulation in the liver, skin, and tumor of a rat model , 1995, Photonics West.
[35] Brian C. Wilson,et al. General-purpose instrument for PDT dosimetry , 1995, Other Conferences.
[36] R. Pottier,et al. On the role of protoporphyrin IX photoproducts in photodynamic therapy. , 1995, Journal of photochemistry and photobiology. B, Biology.
[37] Hubert van den Bergh,et al. In-vivo measurement of fluorescence bleaching of meso-tetra hydroxy phenyl chlorin (mTHPC) in the esophagus and the oral cavity , 1995, European Conference on Biomedical Optics.
[38] C. Gomer,et al. Clinical and preclinical photodynamic therapy , 1995, Lasers in surgery and medicine.
[39] Thomas H. Foster,et al. Oxygen sensitivity of PDT determined from time-dependent electrode measurements in spheroids , 1995, Photonics West.
[40] Dominic J. Robinson,et al. In vivo monitoring of photosensitizer fluorescence during photodynamic therapy , 1995, Other Conferences.
[41] G. Wagnières,et al. Clinical pharmacokinetic studies of photofrin by fluorescence spectroscopy in the oral cavity, the esophagus, and the bronchi , 1995, Cancer.
[42] John Griffiths,et al. Measurement of the photodynamic dose in an optical phantom , 1995, Other Conferences.
[43] Stefan Andersson-Engels,et al. Photodynamic therapy of nonmelanoma skin malignancies with topical delta-amino levulinic acid: diagnostic measurements , 1994, Other Conferences.
[44] J. J. Schuitmaker,et al. Mechanisms for optimising photodynamic therapy: second-generation photosensitisers in combination with mitomycin C. , 1995, British Journal of Cancer.
[45] Claire Davies,et al. Threshold effects of PDT in the normal rat colon with ALA photosensitization , 1994, Other Conferences.
[46] P. Monnier,et al. Optimizing light dosimetry in photodynamic therapy of early stage carcinomas of the esophagus using fluorescence spectroscopy , 1996, Lasers in surgery and medicine.
[47] R. Cubeddu,et al. In vivo absorption spectrum of disulphonated aluminium phthalocyanine in a murine tumour model. , 1996, Journal of photochemistry and photobiology. B, Biology.
[48] T. Dougherty,et al. A brief history of clinical photodynamic therapy development at Roswell Park Cancer Institute. , 1996, Journal of clinical laser medicine & surgery.
[49] N.T. Songhvi,et al. New developments in therapeutic ultrasound , 1996 .
[50] S. Bagdonas,et al. Spectroscopic studies of photobleaching and photoproduct formation of porphyrins used in tumour therapy. , 1996, Journal of photochemistry and photobiology. B, Biology.
[51] S M Evans,et al. Noninvasive imaging of the distribution in oxygen in tissue in vivo using near-infrared phosphors. , 1996, Biophysical journal.
[52] V. Fingar,et al. Vascular effects of photodynamic therapy. , 1996, Journal of clinical laser medicine & surgery.
[53] B. C. Wilson,et al. The sensitivity of normal brain and intracranially implanted VX2 tumour to interstitial photodynamic therapy. , 1996, British Journal of Cancer.
[54] L. Bezdetnaya,et al. Spectroscopic and Biological Testing of Photobleaching of Porphyrins in Solutions * , 1996, Photochemistry and photobiology.
[55] H J Sterenborg,et al. Photodynamic therapy with pulsed light sources: a theoretical analysis , 1996, Physics in medicine and biology.
[56] M. Chopp,et al. Damage Threshold of Normal Rat Brain in Photodynamic Therapy , 1996, Photochemistry and photobiology.
[57] L. Grossweiner,et al. Effects of Photofrin on in vivo skin reflectivity. , 1996, Journal of photochemistry and photobiology. B, Biology.
[58] M S Patterson,et al. Absorbed photodynamic dose from pulsed versus continuous wave light examined with tissue-simulating dosimeters. , 1997, Applied optics.
[59] M G Nichols,et al. The Mechanism of Photofrin Photobleaching and Its Consequences for Photodynamic Dosimetry , 1997, Photochemistry and photobiology.
[60] Lothar Lilge,et al. Photodynamic-therapy-induced alterations of the blood-brain barrier transfer constant of a tracer molecule in normal brain , 1997, Photonics West - Biomedical Optics.
[61] B. Wilson,et al. Changes in in vivo optical properties and light distributions in normal canine prostate during photodynamic therapy. , 1997, Radiation research.
[62] Ting-Yim Lee,et al. In vivo CT measurement of blood-brain transfer constant of iopamidol in human brain tumors , 1992, Journal of Neuro-Oncology.
[63] Brian C. Wilson,et al. Effect of photosensitizer concentration in tissue on the penetration depth of photoactivating light , 1986, Lasers in Medical Science.